EUVIMEDEUVIMED entdecken
Crossref

Challenges and prospects of clinical trials in Nigeria - Lessons from the WHO COVID-19 solidarity plus trial

Adefolarin Opawoye, Vivian Kwaghe, Zaiyad G Habib, Yusuf Jibrin, Ibrahim Maigari, Bashir Hussaini, Olukemi Adekanmbi, Uche Unigwe, Olusola Ayoola, Akin Osibogun, Kolawole Salami, Marie-Pierre Preziosi und 1 weitere

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Adefolarin Opawoye und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lagos University Teaching Hospital, Lagos, Nigeria. Hauptthemen laut MEDLINE: COVID-19, World Health Organization, Randomized Controlled Trials as Topic, SARS-CoV-2. Die Arbeit nennt 12 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conducting randomized clinical trials (RCTs) during a pandemic is essential for obtaining timely evidence on safe and effective treatments, but it presents numerous obstacles. During the COVID-19 pandemic, the World Health Organization (WHO) sponsored multinational RCTs investigating repurposed drugs among hospitalized COVID-19 patients across countries with varying clinical research capacities. In Nigeria, several challenges hindered our progress, including inadequate infrastructure, initial insufficient investigator certification and expertise, and delays in securing regulatory approvals due to bureaucratic hurdles. Despite these challenges, the WHO-sponsored Solidarity Plus Trial (SPT) offered valuable opportunities to enhance research capacity, streamline participant enrolment through electronic randomization, and bolster infection prevention and control measures for healthcare workers. Moreover, the trial enabled us to upgrade infrastructure at multiple sites, facilitating improved case detection through more testing and data collection. A crucial lesson learned was the importance of expediting trial initiation to capitalize on the limited window for data collection during an outbreak. To optimize RCTs during pandemics, we advocate for enhanced community engagement, collaborative efforts across sectors, strengthened research capacity, flexible regulatory frameworks, and the establishment of adaptive clinical trial units. By addressing these challenges and leveraging opportunities, we can significantly enhance the efficiency and impact of RCTs during public health emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19World Health OrganizationRandomized Controlled Trials as TopicSARS-CoV-2HumansNigeriaPandemicsResearch DesignCOVID-19 Drug Treatment

Stichwörter der Autor:innen

COVID-19Clinical trialsGlobal HealthLow-and-middle income countriesPandemics

Autor:innen und Institutionen

  • Lagos University Teaching Hospital, Lagos, Nigeria.
  • University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
  • Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
  • Aminu Kano Teaching Hospital, Kano, Nigeria.
  • University College Hospital, Ibadan, United Kingdom.
  • University of Nigeria Teaching Hospital, Enugu, Nigeria.

Förderung

  • World Health Organization

Zitieren

APA

Opawoye, A., Kwaghe, V., Habib, Z. G., Jibrin, Y., Maigari, I., Hussaini, B., Adekanmbi, O., Unigwe, U., Ayoola, O., Osibogun, A., Salami, K., Preziosi, M. P., & Habib, A. G. (2024). Challenges and prospects of clinical trials in Nigeria - Lessons from the WHO COVID-19 solidarity plus trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107743

Vancouver

Opawoye A, Kwaghe V, Habib ZG, Jibrin Y, Maigari I, Hussaini B, et al. Challenges and prospects of clinical trials in Nigeria - Lessons from the WHO COVID-19 solidarity plus trial. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107743

BibTeX
@article{Opawoye2024,
  author = {Opawoye, Adefolarin and Kwaghe, Vivian and Habib, Zaiyad G and Jibrin, Yusuf and Maigari, Ibrahim and Hussaini, Bashir and Adekanmbi, Olukemi and Unigwe, Uche and Ayoola, Olusola and Osibogun, Akin and Salami, Kolawole and Preziosi, Marie-Pierre and Habib, Abdulrazaq G},
  title = {Challenges and prospects of clinical trials in Nigeria - Lessons from the WHO COVID-19 solidarity plus trial},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107743}
}
Kostenlos starten →